EDMONTON, April 28 /CNW/ - (TSX:ISA) - Isotechnika Inc. announced today that collaborators with Lux Biosciences, Inc. are scheduled to present data on the use of voclosporin with Lux’s proprietary topical and new bioerodible polymer/drug products for the treatment of dry eye and other inflammatory eye diseases. These multiple presentations (poster and oral) will take place at the Association for Research in Vision and Ophthalmology (ARVO) conference scheduled from April 27 - May 1 in Fort Lauderdale, Florida.
